Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have a confirmed diagnosis of multiple sclerosis, of any type (including relapsing-remitting, secondary progressive, or primary progressive).
- People who are between 18 and 65 years of age.
- People whose main disability affects movement and who fall within a specific range on a standard MS disability scale (EDSS score of 2 to 6 — confirm with trial site if unsure where this places you).
- People who have not had an MS relapse in the past month.
- People who are able to attend regular outpatient physiotherapy sessions and are motivated to take part in the programme.
- People who are able and willing to complete three rounds of clinical assessments and three MRI scans.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have other conditions that affect their ability to move, such as serious injuries, bone or joint problems, or other neurological conditions.
- People who have an active inflammatory condition or infection at the time the programme is due to start, which could affect their safety or the results.
- People who have changed their MS or steroid treatment in the past month, or who have a treatment change planned during the programme.
- People who cannot have an MRI scan, for example due to being in the first trimester of pregnancy, or having a pacemaker, defibrillator, older metal joint replacements, or other metal implants in their body.
- People who plan to be away for an extended period during the programme, such as for a holiday or a surgical procedure.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kamila Rasova, prof. Ph.D., Faculty Hospital Kralovske Vinohrady and Charles University in Prague, Czech Republic
Phone: +420737449662
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in MS-specific health impact (Multiple Sclerosis Impact Scale, MSIS-29 total score)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.